| Date Filed | Type | Description |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 02/14/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/14/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/14/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/12/2020 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 0.5% stake in Aevi Genomic Medicine, Inc. |
| 02/12/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/12/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/12/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/12/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/12/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/12/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/12/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/12/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/12/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/12/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/12/2020 |
RW
| Form RW - Registration Withdrawal Request: |
| 02/07/2020 |
SC 13D
| ASTRAZENECA PLC reports a 16.7% stake in AEVI GENOMIC MEDICINE, INC. |
| 02/03/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 02/03/2020 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...|
Docs:
|
"Certificate of Formation of Second Genie Merger Sub, LLC",
"Limited Liability Company Agreement of Second Genie Merger Sub, LLC",
"Option Termination Agreement, effective February 3, 2020, by and between Aevi Genomic Medicine, Inc. and Michael F. Cola",
"Option Termination Agreement, effective February 3, 2020, by and between Aevi Genomic Medicine, Inc. and Garry A. Neil" |
|
| 01/06/2020 |
SC 13D/A
| Children's Hospital of Philadelphia Foundation reports a 49.1% stake in Aevi Genomic Medicine, Inc. |
| 12/31/2019 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 12/23/2019 |
8-K
| Quarterly results |
| 12/23/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/23/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/10/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/10/2019 |
8-K/A
| Acquisition/merger/asset purchase announced |
| 12/10/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/06/2019 |
SC 13D/A
| Children's Hospital of Philadelphia Foundation reports a 52.3% stake in Aevi Genomic Medicine, Inc. |
| 12/05/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 12/05/2019 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Agreement and Plan of Merger and Reorganization, among Aevi Genomic Medicine, Inc., Genie Merger Sub, Inc., Second Genie Merger Sub, LLC and Cerecor Inc. (including the Form of Contingent Value Rights Agreement)",
"Form of Voting Agreement of Aevi Genomic Medicine, Inc.",
"Promissory Note for License Expenses, by and between Cerecor Inc. and Aevi Genomic Medicine, Inc",
"Promissory Note for Operating Expenses, by and between Cerecor Inc. and Aevi Genomic Medicine, Inc",
"Cerecor to Acquire Aevi Genomic Medicine" |
|
| 12/05/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 11/22/2019 |
8-K
| Other Events |
| 11/20/2019 |
SC 13D/A
| Children's Hospital of Philadelphia Foundation reports a 47.5% stake in Aevi Genomic Medicine, Inc. |
|